Lostam BioPharmaceuticals

Treatment for Bacterial Infections

Health Tech & Life Sciences

Non Active, Aug 2016

Pre-Funding Nazareth Founded 2009

Total raised

—

Stage

Pre-Funding

Founded

2009

Headcount

8,472

Nazareth

Sector

Health Tech & Life Sciences

About

Lostam BioPharmaceuticals is developing a novel class of protein therapeutics (biologics) aimed atpreventing and treating lethal Gram-negative bacterial infections associated primarily with the hospital setting.

Sectors & technology

Primary sector

Health Tech & Life Sciences

Sub-sectors

Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentBiomaterials & Tissue EngineeringMedical DevicesMedical Treatment & Therapeutics

Technologies

Biologicals

Target customers

Healthcare & Life SciencesHealthcareProviders

Business model

B2B

Name	Lostam BioPharmaceuticals
Slug	lostam-biopharmaceuticals
Type	Israeli Startup
Founded	2009
HQ city	Nazareth
HQ country	IL
Primary sector	[object Object]
Sectors	[object Object], [object Object], [object Object], [object Object], [object Object], [object Object]
Business models	B2B
Target customers	[object Object], [object Object], [object Object]
Status	inactive
Current stage	Pre-Funding
Public stage	Pre-Funding
Total raised (USD)	0
Israeli Companies Registrar	514335603

Name	Role	LinkedIn
Lewis F. Neville, PhD
Azmi Adawi

Lostam BioPharmaceuticals

About

Sectors & technology

Tags